Kaia Health is a leading digital therapeutics company that creates evidence-based treatments for a range of disorders including musculoskeletal conditions and COPD.
Kaia Health uses computer vision technology for real-time posture tracking via the smartphone camera to deliver human-hands-free physiotherapy.
Kaia Health was founded in 2016 by Konstantin Mehl and Manuel Thurner. The company is headquartered in Munich, Bavaria, Germany, with an office in New York, New York.
Kaia Health uses innovative technology, including artificial intelligence and computer vision, and works with medical experts to create an interdisciplinary digital approach. This empowers and motivates individuals to take control and self-manage their condition with effective, non-pharmacological, digital alternatives at low costs.
Kaia launched a new musculoskeletal-focused product line with case review services, triage algorithms and interoperability with certain healthcare providers’ networks—while expanding coverage to pain in the back, neck, hip, knee, shoulder, hand, wrist, foot and ankle.
Kaia's partners can provide additional medical services to relevant patients, both general and specialty care solutions, including disease management programs, PT, telemedicine, care navigation, and expert medical opinion services. Partners also get access to detailed treatment history on referred patients from Kaia, including via APIs.
Kaia is a market leaders in digital therapeutics across the globe, with 60 million people worldwide have access to its digital platforms, with more than 450,000 treated through agreements with employers, providers and health plans.
Kaia Health is backed by Optum Ventures, Balderton Capital, Idinvest, Heartcore Capital, capital300 and others. The company raised $75M in Series C round on Apr 28, 2021. This brings Kaia's total funding to $123M to date.